Made available in DSpace on 2014-06-11T19:31:00Z (GMT). No. of bitstreams: 0
Previous issue date: 2003Bitstream added on 2014-06-13T20:01:22Z : No. of bitstreams: 1
sato_dn_dr_araiq.pdf: 232098 bytes, checksum: fef9938402c38520312a4f3268b1687d (MD5) / O aumento de cepas de Mycobacterium tuberculosis resistentes às drogas utilizadas no esquema de tratamento convencional, principalmente por falha terapêutica, têm levado os pesquisadores à busca de novas drogas. Entretanto, faz-se necessário desenvolver novas metodologias para a determinação da atividade bactericida destes compostos. Este estudo descreve a padronização de uma metodologia rápida para triagem de atividade intra e extracelular de novos compostos, empregando Mycobacterium tuberculosis H37Rv ATCC 27294 e Mycobacterium tuberculosis Erdman ATCC 35801, ambas contendo o plasmídio pSMT1 com o gene luxA e luxB proveniente do Vibrio harveyi. A rifampicina e a isoniazida foram empregadas como droga de referência na padronização da técnica da luciferase extracelular, obtendo-se resultados de Concentração Inibitória Mínima de 0,03 μg/mL, para ambas as drogas, valores estes compatíveis com os da técnica de Alamar Blue. Para a padronização da técnica da luciferase intracelular foi utilizado o M. tuberculosis Erdman ATCC 35801 contendo o plasmídio pSMT internalizado em células de macrófagos J774. A droga de referência empregada foi a rifampicina obtendo-se um... / There has been an increase of Mycobacterium tuberculosis strains that are resistant to the current anti-TB agents, mainly through acquired resistance by therapeutic failure. This fact has underscored the need of a quick development of antimycobacterial drugs that are more effective than those currently in use. Moreover, new methodologies to determine the bactericidal activity of these compounds have been proposed. This study describes the use of bioluminescent strains of Mycobacterium tuberculosis H37Rv – ATCC 27974 and Mycobacterium tuberculosis Erdman ATCC 35801 both containing the plasmid pSMT1 constructed with luxA and luxB genes from Vibrio harveyi in a screening to evaluate the antimycobacterial activities of anti-TB agents. Standardization of the technique was performed using isoniazid and rifampicin, as drugs standard. The results of Minimal Inhibitory Concentration (MIC) were 0.03 μg/mL and 0.03 μg/mL, respectively. These values were totally compatible with those obtained by Microplate Alamar Blue Assay (MABA). Standardization of bioluminescence measurements of intracellular antimycobacterial activity was performed using the J774 murine...(Complete abstract, click electronic access below)
| Identifer | oai:union.ndltd.org:IBICT/oai:repositorio.unesp.br:11449/100761 |
| Date | January 2003 |
| Creators | Sato, Daisy Nakamura [UNESP] |
| Contributors | Universidade Estadual Paulista (UNESP), Leite, Clarice Queico Fujimura [UNESP] |
| Publisher | Universidade Estadual Paulista (UNESP) |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | Portuguese |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/doctoralThesis |
| Format | 76 f. : il. |
| Source | Aleph, reponame:Repositório Institucional da UNESP, instname:Universidade Estadual Paulista, instacron:UNESP |
| Rights | info:eu-repo/semantics/openAccess |
| Relation | -1, -1 |
Page generated in 0.0024 seconds